Cargando…

Reduction of Breast Cancer Relapses with Perioperative Non-Steroidal Anti-Inflammatory Drugs: New Findings and a Review

To explain a bimodal pattern of hazard of relapse among early stage breast cancer patients identified in multiple databases, we proposed that late relapses result from steady stochastic progressions from single dormant malignant cells to avascular micrometastases and then on to growing deposits. How...

Descripción completa

Detalles Bibliográficos
Autores principales:	Retsky, Michael, Demicheli, Romano, Hrushesky, William J.M, Forget, Patrice, Kock, Marc De, Gukas, Isaac, Rogers, Rick A, Baum, Michael, Sukhatme, Vikas, Vaidya, Jayant S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3831877/ https://www.ncbi.nlm.nih.gov/pubmed/23992307 http://dx.doi.org/10.2174/09298673113209990250

Ejemplares similares

Promising development from translational or perhaps anti-translational research in breast cancer
por: Retsky, Michael, et al.
Publicado: (2012)

Surgery Triggers Outgrowth of Latent Distant Disease in Breast Cancer: An Inconvenient Truth?
por: Retsky, Michael, et al.
Publicado: (2010)

Breast cancer and the black swan
por: Retsky, Michael, et al.
Publicado: (2020)

Hypothesis: primary antiangiogenic method proposed to treat early stage breast cancer
por: Retsky, Michael W, et al.
Publicado: (2009)

Interpreting Breast Cancer Survival Data by the Hazard Function: Remarkable Findings from Event Dynamics
por: Demicheli, Romano, et al.
Publicado: (2020)

Menopausal status dependence of the timing of breast cancer recurrence after surgical removal of the primary tumour
por: Demicheli, Romano, et al.
Publicado: (2004)

Multimodal Hazard Rate for Relapse in Breast Cancer: Quality of Data and Calibration of Computer Simulation
por: Retsky, Michael, et al.
Publicado: (2014)

Recent translational research: computational studies of breast cancer
por: Retsky, Michael, et al.
Publicado: (2005)

Hypothesis: Induced angiogenesis after surgery in premenopausal node-positive breast cancer patients is a major underlying reason why adjuvant chemotherapy works particularly well for those patients
por: Retsky, Michael, et al.
Publicado: (2004)

Breast Cancer Relapse, Post-Surgical Confusion, and Dementia in the Elderly: An Unexpected Connection but with the Same Proposed Solution
por: Retsky, Michael W., et al.
Publicado: (2018)

Recurrence dynamics does not depend on the recurrence site
por: Demicheli, Romano, et al.
Publicado: (2008)

Late effects of adjuvant chemotherapy adumbrate dormancy complexity in breast cancer
por: Demicheli, Romano, et al.
Publicado: (2020)

It May Be Possible to Prevent both Early and Late Relapses in Breast Cancer; Perhaps This Is an Opportunity for Sensors or Biosensors to Help
por: Retsky, Michael
Publicado: (2020)

Recurrence and mortality according to Estrogen Receptor status for breast cancer patients undergoing conservative surgery. Ipsilateral breast tumour recurrence dynamics provides clues for tumour biology within the residual breast
por: Demicheli, Romano, et al.
Publicado: (2010)

Perioperative NSAIDs and Long-Term Outcomes After cancer Surgery: a Systematic Review and Meta-analysis
por: Shaji, Shebin, et al.
Publicado: (2021)

Global adoption of single-shot targeted intraoperative radiotherapy (TARGIT-IORT) for breast cancer—better for patients, better for healthcare systems
por: Vaidya, Jayant Sharad, et al.
Publicado: (2022)

Single-dose intraoperative radiotherapy during lumpectomy for breast cancer: an innovative patient-centred treatment
por: Vaidya, Jayant S., et al.
Publicado: (2021)

Perioperative steroid supplementation: Controversies continues!!
por: Sethi, Priyanka, et al.
Publicado: (2017)

Cancer surgery induces inflammation, immunosuppression and neo-angiogenesis, but is it influenced by analgesics?
por: Forget, Patrice, et al.
Publicado: (2013)

Is the Neutrophil-to-Lymphocyte Ratio more correlated than C-reactive protein with postoperative complications after major abdominal surgery?
por: Forget, Patrice, et al.
Publicado: (2015)

Small but serious risk of perioperative steroid use
por: Kim, Tae-Yop
Publicado: (2017)

The Repurposing Drugs in Oncology (ReDO) Project
por: Pantziarka, Pan, et al.
Publicado: (2014)

New Concepts in Breast Cancer Emerge from Analyzing Clinical Data Using Numerical Algorithms
por: Retsky, Michael
Publicado: (2009)

Comments on John D. Keen and James E. Keen, What is the point: will screening mammography save my life? BMC Medical Informatics and Decision Making, 2009
por: Retsky, Michael
Publicado: (2009)

An argument for discovery-driven research: from physicist to cancer researcher
por: Retsky, Michael
Publicado: (2014)

Repurposing Drugs in Oncology (ReDO)—mebendazole as an anti-cancer agent
por: Pantziarka, Pan, et al.
Publicado: (2014)

Repurposing Drugs in Oncology (ReDO)—itraconazole as an anti-cancer agent
por: Pantziarka, Pan, et al.
Publicado: (2015)

Repurposing Drugs in Oncology (ReDO)—diclofenac as an anti-cancer agent
por: Pantziarka, Pan, et al.
Publicado: (2016)

Repurposing drugs in oncology (ReDO)—cimetidine as an anti-cancer agent
por: Pantziarka, Pan, et al.
Publicado: (2014)

Repurposing Drugs in Oncology (ReDO)—nitroglycerin as an anti-cancer agent
por: Sukhatme, Vidula, et al.
Publicado: (2015)

Guest Editor's Concluding Remarks—Advances in Usage of ANN, Discussion of an Unsolved Problem, and Some Differences between Papers Written by Engineers and by Physicians
por: Retsky, Michael W.
Publicado: (2009)

Available drugs and supplements for rapid deployment for treatment of COVID-19
por: Cicka, Danielle, et al.
Publicado: (2021)

Fluvoxamine: A Review of Its Mechanism of Action and Its Role in COVID-19
por: Sukhatme, Vikas P., et al.
Publicado: (2021)

Comparative benefit from small tumour size and adjuvant chemotherapy: clues for explaining breast cancer mortality decline
por: Demicheli, Romano, et al.
Publicado: (2014)

Late Recurrence in Breast Cancer: To Run after the Oxen or to Try to Close the Barn?
por: Demicheli, Romano, et al.
Publicado: (2021)

From Oncological Paradigms to Non-Communicable Disease Pandemic. The Need of Recovery Human Biology Evolution
por: Biganzoli, Elia, et al.
Publicado: (2021)

Repurposing Drugs in Oncology (ReDO)—Propranolol as an anti-cancer agent
por: Pantziarka, Pan, et al.
Publicado: (2016)

Repurposing drugs in oncology (ReDO)—selective PDE5 inhibitors as anti-cancer agents
por: Pantziarka, Pan, et al.
Publicado: (2018)

Repurposing Drugs in Oncology (ReDO)—clarithromycin as an anti-cancer agent
por: Van Nuffel, An MT, et al.
Publicado: (2015)

Continuous B-cell depletion in frequently relapsing, steroid-dependent and steroid-resistant nephrotic syndrome
por: Cortazar, Frank B, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4nqll1grd6g6u3u4l36577jvph